Pharmacological Treatment of Epilepsy in Elderly Patients

키워드

참고문헌 (56)

1. Orimo H, "Reviewing the definition of elderly", Nihon Ronen Igakkai Zasshi, 43, pp.27~34 (2006)
2. Chen LA, "Epilepsy in the elderly", Int J Gerontol, 6, pp.63~67 (2012)
3. Brodie MJ, "Epilepsy in elderly people", BMJ, 331, pp.1317~1322 (2005)
4. Stephen LJ, "Epilepsy in elderly people", Lancet, 355, pp.1441~1446 (2000)
5. Acharya JN, "Epilepsy in the elderly : special considerations and challenges", Ann Indian Acad Neurol, 17(Suppl 1), pp.S18~S26 (2014)
6. Pugh MJ, "New-onset epilepsy risk factors in older veterans", J Am Geriatr Soc, 57, pp.237~242 (2009)
7. Lee SK, "Epilepsy in the elderly : treatment and consideration of comorbid diseases", J Epilepsy Res, 9, pp.27~35 (2019)
8. Tanaka A, "Clinical characteristics and treatment responses in new-onset epilepsy in the elderly", Seizure, 22, pp.772~775 (2013)
9. Ramsay RE, "Special considerations in treating the elderly patient with epilepsy", Neurology, 62, pp.S24~S29 (2004)
10. Cloyd J, "Epidemiological and medical aspects of epilepsy in the elderly", Epilepsy Res, 68(Suppl 1), pp.S39~S48 (2006)
11. Benbir G, "The epidemiology of post-stroke epilepsy according to stroke subtypes", Acta Neurol Scand, 114, pp.8~12 (2006)
12. Bladin CF, "Seizures after stroke : a prospective multicenter study", Arch Neurol, 57, pp.1617~1622 (2000)
13. Ferlazzo E, "Epilepsy in cerebrovascular diseases : review of experimental and clinical data with meta-analysis of risk factors", Epilepsia, 57, pp.1205~1214 (2016)
14. Gasparini S, "Hypertension, seizures, and epilepsy : a review on pathophysiology and management", Neurol Sci, 40, pp.1775~1783 (2019)
15. Gasparini S, "Epilepsy associated with Leukoaraiosis mainly affects temporal lobe : a casual or causal relationship?", Epilepsy Res, 109, pp.1~8 (2015)
16. Martin RC, "Psychiatric and neurologic risk factors for incident cases of new-onset epilepsy in older adults : data from U. S. Medicare beneficiaries", Epilepsia, 55, pp.1120~1127 (2014)
17. Mendez M, "Seizures in elderly patients with dementia : epidemiology and management", Drugs Aging, 20, pp.791~803 (2003)
18. Imfeld P, "Seizures in patients with Alzheimer’s disease or vascular dementia : a populationbased nested case-control analysis", Epilepsia, 54, pp.700~707 (2013)
19. Ostrom QT, "CBTRUS statistical report : primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016", Neuro Oncol, 21, pp.v1~v100 (2019)
20. Kargiotis O, "Epilepsy in the cancer patient", Cancer Chemother Pharmacol, 67, pp.489~501 (2011)
21. Brodie MJ, "Epilepsy in later life", Lancet Neurol, 8, pp.1019~1030 (2009)
22. Collins NS, "Elders with epilepsy", Med Clin North Am, 90, pp.945~966 (2006)
23. Bergey GK, "Initial treatment of epilepsy : special issues in treating the elderly", Neurology, 63, pp.S40~S48 (2004)
24. Rohracher A, "Status epilepticus in the elderly-a retrospective study on 120patients", Epilepsy Res, 127, pp.317~323 (2016)
25. Leppik IE, "Status epilepticus in the elderly", Epilepsia, 59(Suppl 2), pp.140~143 (2018)
26. Glauser T, "Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes", Epilepsia, 54, pp.551~563 (2013)
27. Kanner AM, "Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs II: treatment-resistant epilepsy: report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology", Epilepsy Curr, 18, pp.269~278 (2018)
28. Kaur U, "Antiepileptic drug therapy in the elderly : a clinical pharmacological review", Acta Neurol Belg, 119, pp.163~173 (2019)
29. Italiano D, "Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age : an update", Clin Pharmacokinet, 52, pp.627~645 (2013)
30. Perucca E, "Clinically relevant drug interactions with antiepileptic drugs", Br J Clin Pharmacol, 61, pp.246~255 (2006)
31. Chuang YC, "Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis", Epilepsia, 53, pp.120~128 (2012)
32. Kwan P, "Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy", Neurology, 60, pp.S2~S12 (2003)
33. Brodie MJ, "Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group", Epilepsy Res, 37, pp.81~87 (1999)
34. Rowan AJ, "New onset geriatric epilepsy : a randomized study of gabapentin, lamotrigine, and carbamazepine", Neurology, 64, pp.1868~1873 (2005)
35. Werhahn KJ, "A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy", Epilepsia, 56, pp.450~459 (2015)
36. Pohlmann-Eden B, "Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study", BMC Neurol, 16, pp.149~ (2016)
37. Lezaic N, "The medical treatment of epilepsy in the elderly : a systematic review and meta-analysis", Epilepsia, 60, pp.1325~1340 (2019)
38. Byun JI, "Treatment of epilepsy in adults : expert opinion in South Korea", Epilepsy Behav, 105, pp.106942~ (2020)
39. Saetre E, "An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly", Epilepsia, 48, pp.1292~1302 (2007)
40. Ferrendelli JA, "Use of levetiracetam in a population of patients aged 65 years and older : a subset analysis of the KEEPER trial", Epilepsy Behav, 4, pp.702~709 (2003)
41. Alsaadi TM, "Levetiracetam monotherapy for elderly patients with epilepsy", Seizure, 13, pp.58~60 (2004)
42. Trinka E, "Epilepsy : comorbidity in the elderly", Acta Neurol Scand Suppl, 180, pp.33~36 (2003)
43. Kaur U, "A prospective observational pilot study of adverse drug reactions in patients admitted in the geriatric ward of a tertiary hospital in North India", Curr Pharmacogenomics Person Med, 16, pp.147~155 (2018)
44. Pugh MJ, "Choice of initial antiepileptic drug for older veterans : possible pharmacokinetic drug interactions with existing medications", J Am Geriatr Soc, 58, pp.465~471 (2010)
45. Zaccara G, "Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs", Epileptic Disord, 16, pp.409~431 (2014)
46. Steffel J, "The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation", Eur Heart J, 39, pp.1330~1393 (2018)
47. Díaz RA, "Antiepileptic drug interactions", Neurologist, 14, pp.S55~S65 (2008)
48. Ryvlin P, "Optimizing therapy of seizures in stroke patients", Neurology, 67, pp.S3~S9 (2006)
49. Mintzer S, "Should enzyme-inducing antiepileptic drugs be considered first-line agents?", Epilepsia, 50(Suppl 8), pp.42~50 (2009)
50. Boggs JG, "Seizure management in the setting of hepatic disease", Curr Treat Options Neurol, 13, pp.333~345 (2011)
51. Lacerda G, "Optimizing therapy of seizures in patients with renal or hepatic dysfunction", Neurology, 67, pp.S28~S38 (2006)
52. Stefan H, "Epilepsy in the elderly : facts and challenges", Acta Neurol Scand, 124, pp.223~237 (2011)
53. Svalheim S, "Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine", Acta Neurol Scand Suppl, pp.30~33 (2010)
54. Kim DW, "Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy", Epilepsia, 54, pp.e146~e149 (2013)
55. Petty SJ, "Anti-epileptic medication and bone health", Osteoporos Int, 18, pp.129~142 (2007)
56. Sheth RD, "Bone mineral density with lamotrigine monotherapy for epilepsy", Pediatr Neurol, 37, pp.250~254 (2007)

관련 논문AI추천